Soleus Capital logo

Soleus Capital

North America, Connecticut, United States, Greenwich

Description

Soleus Capital is a private equity firm.

Investor Profile

Soleus Capital has made 64 investments, with 8 in the past 12 months and 16% as lead.

Stage Focus

  • Post Ipo Equity (31%)
  • Series B (23%)
  • Series C (20%)
  • Series D (13%)
  • Series A (5%)
  • Series Unknown (3%)
  • Post Ipo Debt (2%)
  • Undisclosed (2%)
  • Series E (2%)

Country Focus

  • United States (78%)
  • United Kingdom (9%)
  • Canada (5%)
  • Denmark (3%)
  • Israel (2%)
  • France (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical Device
  • Medical
  • Pharmaceutical
  • Life Science
  • Health Diagnostics
  • Genetics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Soleus Capital frequently co-invest with?

Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 12
CA
North America, Massachusetts, United States, Boston
Co-Investments: 10
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 8
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 8
RTW Investments
North America, New York, United States, New York
Co-Investments: 10
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 22
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 8
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 17
Sands Capital Ventures
North America, Virginia, United States, Arlington
Co-Investments: 10
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 14

Which angels does Soleus Capital often collaborate with?

ME
Europe, England, United Kingdom
Shared Deals: 1
JM
North America, United States
Shared Deals: 1
BS
North America, Minnesota, United States, Minneapolis
Shared Deals: 1
AU
Europe, Hallands Lan, Sweden, Kungsbacka
Shared Deals: 1
Mark W. Hahn
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1
VS
North America, Massachusetts, United States, Boston
Shared Deals: 1
David Zaccardelli
North America, United States
Shared Deals: 1
DE
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1

What are some of recent deals done by Soleus Capital?

Pillar Biosciences

Natick, Massachusetts, United States

Pillar Biosciences specializes in sequencing technology platform and proprietary data analysis toolkit.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownMay 27, 2025
Amount Raised: $34,500,000
Jade Biosciences

Waltham, Massachusetts, United States

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Health CareTherapeutics
Post Ipo EquityApr 29, 2025
Amount Raised: $300,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
OrganOx

Oxford, Oxfordshire, United Kingdom

OrganOx is a medical technology company.

Health CareMedicalMedical Device
Series UnknownFeb 24, 2025
Amount Raised: $142,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityFeb 3, 2025
Amount Raised: $185,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000
Blue Earth Therapeutics

Oxford, Oxfordshire, United Kingdom

Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.

Health CareMedicalPharmaceuticalTherapeutics
Series AOct 30, 2024
Amount Raised: $76,500,000

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
UndisclosedOct 29, 2024
Amount Raised: $200,000,000
Inhibikase Therapeutics

Atlanta, Georgia, United States

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

Health CareHealth DiagnosticsTherapeutics
Post Ipo EquityOct 9, 2024
Amount Raised: $110,000,000
Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000